Washington SunGrowers Industry Association
(WSIA)

The board received a short briefing on cannabis rulemaking, adopted a permanent ban on vitamin E acetate, and heard from a public eager to support farmers and consumers.

Board members voted to restart rulemaking on synthesized cannabinoids and heard directly from two advocates for the practice amongst many more otherwise opposed.

Details of a board member’s discussion with state counsel on synthesized delta-9-THC led to conversation about the policy statements and agency regulatory powers beyond rulemaking.

The WSLCB Board would learn more about the subject of synthesized delta-9-THC the day before the social equity task force work group on licensing discusses the “State of the Industry.”

The board heard from concerned cannabis stakeholders about legal, health, and economic risks of failing to enforce a prohibition on the use of synthesized cannabinoids in I-502.

Members asked about the potential to include consideration of synthesized delta-9-THC in open rulemaking and had a lengthy discussion on the tone of official statements on the matter.

Members introduced themselves, heard about their work group responsibilities, and began exploring potential changes to cannabis business licensing for social equity applicants.

The day before releasing a policy statement on delta-8-THC and other derived cannabinoids, board and staff discussed their work amidst often anecdotal input from stakeholders.

At the request of WSLCB and with some hedging after hearing from stakeholders, the Pharmacy Commission affirmed a “plain language reading” of the controlled substances act definition of ‘THC’.

The new WSLCB Chair provided more expansive remarks during a public introduction to Cannabis Advisory Council representatives whose comments varied from friendly to confrontational.